Announcements Trials
Browse Landscape

Status

Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 12Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Surveys and Questionnaires 39Blood Specimen Collection 24Specimen Handling 14Radiotherapy 12Interviews as Topic 10Surgical Procedures, Operative 9Observation 9Magnetic Resonance Spectroscopy 9Drug Therapy 9Data Collection 8Immunotherapy 7Watchful Waiting 5Tomography, X-Ray Computed 5Radiosurgery 5Nivolumab 5Mental Status and Dementia Tests 5Mastectomy, Segmental 5Biopsy 5ribociclib 4palbociclib 4Therapeutics 4Positron Emission Tomography Computed Tomography 4Magnetic Resonance Imaging 4Ipilimumab 4Immune Checkpoint Inhibitors 4High-Throughput Nucleotide Sequencing 4Echocardiography 4Bevacizumab 4lorlatinib 3atezolizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Observational × polatuzumab vedotin × Clear all
NCT05954910 2026-05-01

A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma

Hoffmann-La Roche

Active not recruiting
1,000 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡